Genomic instability and aneuploidy are hallmarks of the progressing CML and concur with BCR-ABL mutations encoding resistance to TKI and/or development of additional chromosomal aberrations (ACA) in addition to the Philadelphia chromosome (Ph) (= clonal evolution). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.